FDA chief says warning labels deterred women from using menopause hormone therapy: “It’s an American tragedy”

The U.S. Food and Drug Administration has made a groundbreaking decision to remove the “black box” warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms. This move is expected to encourage more women to seek treatment for these common and often debilitating conditions. FDA Commissioner Dr. Marty Makary described the removal of these warning labels as the end of a decades-long “fear machine” and referred to the demonization of hormone replacement therapy (HRT) as “an American tragedy.”

According to Makary, hormone replacement therapy can have significant health benefits for women, particularly in reducing the risk of heart attacks, which are the leading cause of death among women. The affected products include medications containing estrogen and progesterone, systemic estrogen, and topical estrogen. The decision to remove the warning labels comes after a reassessment of the research that led to their implementation over 20 years ago.

Recent studies have shown that the benefits of hormone therapy outweigh the risks for many women, especially if it is initiated in the early years of menopause, before the age of 60. These benefits include reducing the risk of cognitive decline, Alzheimer’s disease, and osteoporosis, which is a major contributing factor to hip fractures in postmenopausal women. Hormone therapy can also help alleviate a wide range of menopausal symptoms such as hot flashes, insomnia, mood swings, and joint pain.

Makary criticized the medical community for steering millions of women away from hormone therapy due to fears about breast cancer, which he described as one of the biggest mistakes in modern medicine. He emphasized the importance of starting hormone therapy soon after menopause or perimenopause to maximize its benefits, particularly in preventing bone loss and reducing the risk of osteoporosis.

While hormone therapy is the most effective treatment for menopausal symptoms, it may not be suitable for all women, especially those with a history of breast cancer. The FDA recently approved a new non-hormonal option called Lynkuet, which targets the brain pathways involved in regulating body temperature. This alternative treatment provides additional options for women who cannot or prefer not to use hormone therapy.

Despite the prevalence of menopause, research funding and medical education on the topic have historically been limited. However, with more women entering the medical field, there is a growing awareness of the importance of addressing menopause and providing evidence-based treatments to improve women’s health and quality of life. Women’s health concerns have long been dismissed or overlooked by medical professionals, but a new movement is beginning to gain momentum. It seems that women are no longer willing to accept the status quo and are demanding better care from their doctors.

According to recent reports, women are increasingly frustrated with the lack of attention and proper diagnosis they receive when seeking medical help. They are starting to speak up and say, “Hey, wait a minute, this is something where women are coming to their doctors and they’re not getting the right answer.”

This shift in attitude is long overdue and is sparking important conversations about the gender bias that exists in the healthcare system. Women are often not taken seriously when they report symptoms or concerns, which can lead to misdiagnosis or delayed treatment. This can have serious consequences for their health and well-being.

It is crucial that healthcare providers listen to their female patients and take their concerns seriously. Women have unique health needs that must be addressed with care and understanding. By ignoring or dismissing these needs, doctors are doing a disservice to their patients and perpetuating a harmful cycle of neglect.

As more and more women speak out about their experiences, the hope is that the medical community will take notice and make changes to improve the quality of care for women. It is essential that women feel heard and supported when seeking medical help, and that their concerns are taken seriously.

In the coming months and years, it will be important to continue the conversation around women’s health and advocate for better care. By raising awareness and demanding change, we can ensure that women receive the respect and attention they deserve when it comes to their health.